Matthew Richard Moore, SVP and Chief Business Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,681 shares at $8.74 ($41K) on 2024-05-02, disclosed to the SEC on 2024-05-03.
Open-market sale of $41k ARQT by SVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |